CASI Pharmaceuticals, Inc. CASI
0.15 USD 0.00 (+0.00%)
Mar 17, 2026, 9:30 AM EDT
0.15 Day range 0.1505
52-week range unavailable
- YTD
- -82.29%
- 1 year
- -92.24%
Revenue & Expenses
Latest period ending Dec 31, 2024 · select a line to chart its full history
Income statement
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 28.54M | 33.88M | 43.11M | 30.17M | 15.14M | |
| 11.15M | 20.05M | 27.28M | 17.61M | 5.63M | |
| -39.43M | -25.28M | -37.27M | -41.84M | -51.53M | |
| -39.26M | -26.94M | -41.01M | -36.65M | -48.29M | |
| -2.56 | -2.02 | -3.01 | -2.69 | -4.37 |
Balance sheet
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 13.47M | 17.08M | 47.11M | 38.70M | 57.06M | |
| 53.67M | 75.27M | 96.23M | 138.30M | 127.73M | |
| 51.82M | 51.10M | 29.30M | 30.34M | 24.16M | |
| 1.85M | 24.16M | 44.57M | 84.50M | 81.54M |
Cash flow
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| -29.22M | -19.97M | -21.09M | -26.84M | -25.89M | |
| 11.24M | -9.67M | 31.16M | -20.69M | -20.72M | |
| 15.43M | -907.00K | -3.27M | 29.64M | 47.15M | |
| -223.00K | -204.00K | -5.47M | -8.94M | 1.20M | |
| -3.62M | -30.03M | 8.41M | -18.36M | 3.44M |